已收盘 03-15 16:00:00 美东时间
0.000
0.00%
Novartis' Fabhalta showed significant efficacy and safety in a Phase 3 IgA nephropathy study, supporting regulatory filings planned for 2026.
10-16 22:50
STEINHAUSEN, Switzerland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NY...
01-29 06:55
/NE PAS DIFFUSER, PUBLIER OU DISTRIBUER A) AUX ÉTATS-UNIS OU À TOUTE PERSONNE...
2024-09-14 01:48
VANCOUVER, BC, March 28, 2024 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) is pleased to announce that its Board of D...
2024-03-28 20:34
Liberty SiriusXM Tracking Stock Group Will Combine with SiriusXM and Form a New Public Company Transaction Builds on SiriusXM's Durable Foundation and Positions Company to Drive Growth and C...
2023-12-12 20:01
STEINHAUSEN, Switzerland, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Transocean Ltd. (NY...
2023-12-12 07:31
IRVING, Texas, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. ("Exe...
2023-12-06 06:31
Agreement strengthens capital structure and balance sheet, bringing in up to $3...
2023-12-06 06:00
SEATTLE and LINZ, Austria, Nov. 22, 2023 /PRNewswire/ -- Kontron America, Incorporated ("Kontron"), a global leader in IoT Technology, and Bsquare Corporation (Nasdaq: BSQR) ("Bsquare"), an ...
2023-11-22 20:00
--The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio's two clinical development candidates, bempikibart (ADX-914) in Phase 2 for the treatment of atopic ...
2023-11-16 20:05